Arda Taşatargil

619 total citations
39 papers, 506 citations indexed

About

Arda Taşatargil is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, Arda Taşatargil has authored 39 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 10 papers in Physiology and 7 papers in Surgery. Recurrent topics in Arda Taşatargil's work include PARP inhibition in cancer therapy (6 papers), Neuropeptides and Animal Physiology (5 papers) and Folate and B Vitamins Research (5 papers). Arda Taşatargil is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), Neuropeptides and Animal Physiology (5 papers) and Folate and B Vitamins Research (5 papers). Arda Taşatargil collaborates with scholars based in Türkiye, Germany and United States. Arda Taşatargil's co-authors include Çiler Çelik-Özenci, Selvinaz Dalaklıoğlu, Sadi S. Özdem, Leyla Satı, Nazif Hikmet Aksoy, Sebahat Özdem, Ramazan Demir, Gamze Tanrιöver, Fedai Erler and Münire Erman Akar and has published in prestigious journals such as European Journal of Pharmacology, Anesthesia & Analgesia and Atherosclerosis.

In The Last Decade

Arda Taşatargil

39 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arda Taşatargil Türkiye 14 110 79 65 61 52 39 506
Ahmed Al-Shukaili Oman 11 115 1.0× 86 1.1× 26 0.4× 58 1.0× 48 0.9× 21 562
Hakan Türkön Türkiye 16 79 0.7× 60 0.8× 98 1.5× 62 1.0× 28 0.5× 52 580
Mukadder Serter Türkiye 12 152 1.4× 76 1.0× 23 0.4× 69 1.1× 35 0.7× 29 620
Yukishige Yanagawa Japan 15 187 1.7× 122 1.5× 83 1.3× 49 0.8× 37 0.7× 39 616
Yıldız Atamer Türkiye 20 77 0.7× 112 1.4× 56 0.9× 30 0.5× 27 0.5× 42 1.0k
Birgit Hoeft Germany 12 94 0.9× 105 1.3× 32 0.5× 18 0.3× 67 1.3× 17 610
Fadia Mahmoud Kuwait 20 133 1.2× 80 1.0× 64 1.0× 15 0.2× 58 1.1× 41 719
Qi Zhao United States 14 329 3.0× 122 1.5× 47 0.7× 63 1.0× 47 0.9× 63 782
Oğuzhan Özcan Türkiye 15 123 1.1× 72 0.9× 33 0.5× 26 0.4× 30 0.6× 62 662

Countries citing papers authored by Arda Taşatargil

Since Specialization
Citations

This map shows the geographic impact of Arda Taşatargil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arda Taşatargil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arda Taşatargil more than expected).

Fields of papers citing papers by Arda Taşatargil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arda Taşatargil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arda Taşatargil. The network helps show where Arda Taşatargil may publish in the future.

Co-authorship network of co-authors of Arda Taşatargil

This figure shows the co-authorship network connecting the top 25 collaborators of Arda Taşatargil. A scholar is included among the top collaborators of Arda Taşatargil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arda Taşatargil. Arda Taşatargil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özbey, Gül, et al.. (2024). Chronotropic Responses to GLP-1 Receptor Agonists and Sitagliptin in Atria from Diabetic Rats. Journal of Cardiovascular Pharmacology. 83(6). 621–634. 1 indexed citations
2.
Dalaklıoğlu, Selvinaz, et al.. (2018). Protective effect of exendin-4 treatment on erectile dysfunction induced by chronic methylglyoxal administration in rats. Peptides. 106. 1–8. 10 indexed citations
3.
Taşatargil, Arda, et al.. (2017). Effects of nesfatin-1 on atrial contractility and thoracic aorta reactivity in male rats. Clinical and Experimental Hypertension. 40(5). 414–420. 11 indexed citations
4.
Dalaklıoğlu, Selvinaz, et al.. (2016). Resveratrol Prevented Lipopolysaccharide-Induced Endothelial Dysfunction in Rat Thoracic Aorta Through Increased eNOS Expression. Balkan Medical Journal. 33(2). 138–143. 10 indexed citations
5.
Dalaklıoğlu, Selvinaz, et al.. (2016). Resveratrol reverses diabetes-related decrement in sildenafil-induced relaxation of corpus cavernosum in aged rats. Aging Clinical and Experimental Research. 29(3). 345–351. 3 indexed citations
6.
Taşatargil, Arda, et al.. (2015). Punicic Acid Induces Endothelium-Dependent Vasorelaxation in Rat Thoracic Aortic Rings. 1(1). 43–49. 2 indexed citations
7.
Çelik-Özenci, Çiler & Arda Taşatargil. (2013). Role of poly(ADP-ribose) polymerases in male reproduction. PubMed. 3(2). e24194–e24194. 28 indexed citations
8.
Köksal, İsmail Türker, et al.. (2011). Potential Role of Poly(ADP‐Ribose) Polymerase Activation in the Pathogenesis of Experimental Left Varicocele. Journal of Andrology. 33(1). 122–132. 11 indexed citations
9.
Dalaklıoğlu, Selvinaz, et al.. (2009). Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury. Toxicology Letters. 192(2). 91–96. 29 indexed citations
10.
Taşatargil, Arda, et al.. (2008). Poly (ADP-Ribose) Polymerase as a Potential Target for the Treatment of Acute Renal Injury Caused by Lipopolysaccharide. Renal Failure. 30(1). 115–120. 17 indexed citations
11.
Taşatargil, Arda, et al.. (2006). Effects of vitamin K1 supplementation on vascular responsiveness and oxidative stress in a rat femoral osteotomy model. Cell Biochemistry and Function. 25(5). 485–490. 8 indexed citations
12.
Taşatargil, Arda, et al.. (2006). Homocysteine-induced changes in vascular reactivity of guinea-pig pulmonary arteries: Role of the oxidative stress and poly (ADP-ribose) polymerase activation. Pulmonary Pharmacology & Therapeutics. 20(3). 265–272. 17 indexed citations
13.
Taşatargil, Arda, et al.. (2006). Changes in Atrium and Thoracic Aorta Reactivity to Adenosinergic and Adrenergic Agonists in Experimental Hyperhomocysteinemia. Journal of Cardiovascular Pharmacology. 47(5). 673–679. 4 indexed citations
14.
Taşatargil, Arda, et al.. (2005). Minimally Invasive Saphenous Vein Harvesting Using a Laryngoscope: Procedural, Functional, and Morphologic Evaluation. The Heart Surgery Forum. 8(6). E425–E430. 5 indexed citations
15.
Taşatargil, Arda, et al.. (2005). Comparison of the Vasodilatory Effect of Nadroparin, Enoxaparin, Dalteparin, and Unfractioned Heparin in Human Internal Mammary Artery. Journal of Cardiovascular Pharmacology. 45(6). 550–554. 22 indexed citations
16.
Taşatargil, Arda, et al.. (2005). Unfractioned Heparin Produces Vasodilatory Action on Human Internal Mammary Artery by Endothelium-Dependent Mechanisms. Journal of Cardiovascular Pharmacology. 45(2). 114–119. 12 indexed citations
17.
Taşatargil, Arda, et al.. (2005). Inhibition of poly(ADP-ribose) polymerase prevents vascular hyporesponsiveness induced by lipopolysaccharide in isolated rat aorta. Pharmacological Research. 51(6). 581–586. 12 indexed citations
18.
19.
Taşatargil, Arda, et al.. (2004). Poly(ADP-Ribose) Polymerase Inhibition Prevents Homocysteine-Induced Endothelial Dysfunction in the Isolated Rat Aorta. Pharmacology. 72(2). 99–105. 19 indexed citations
20.
Taşatargil, Arda, et al.. (2004). Effects of Short-Term Exposure to Homocysteine on Vascular Responsiveness of Human Internal Mammary Artery. Journal of Cardiovascular Pharmacology. 43(5). 692–697. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Al-Shukaili Breakdown of academic impact, for papers by Hakan Türkön Breakdown of academic impact, for papers by Mukadder Serter Breakdown of academic impact, for papers by Yukishige Yanagawa Breakdown of academic impact, for papers by Yıldız Atamer Breakdown of academic impact, for papers by Birgit Hoeft Breakdown of academic impact, for papers by Fadia Mahmoud Breakdown of academic impact, for papers by Qi Zhao Breakdown of academic impact, for papers by Oğuzhan Özcan
Rankless by CCL
2026